B. Braun Medical SAS (B Braun)

Results

Trendlines to report a loss for 1HFY2022 with US$7.9 mil portfolio company write-off

Trendlines is expected to report its results on Aug 10.

Trendlines reveals MVP Stimatix valued at US$43 mil

SINGAPORE (Apr 9): The Trendlines Group has revealed that colostomy-device company Stimatix GI is its “Most Valuable Portfolio" company.
×